GlassScriptPhysician profile
Stephen Paul Rogitz
NPI 1245888767
$2,031.47
in general payments reported to CMS, 2019-2025
7 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.02 · 2022: $159 · 2023: $1,187 · 2024: $496 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852 · Travel and Lodging: $791 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.53 |
| Travel and Lodging | $790.92 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,034.92 | 2023 | Da Vinci Surgical System, Davinci Xi |
| Getinge USA Sales, LLC | $605.91 | 2022-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Baxter Healthcare | $150.53 | 2024 | |
| Ethicon US, LLC | $86.02 | 2021-2024 | Ethicon |
| Smith+Nephew, INC. | $77.29 | 2023 | Pico, Renasys Go V2 Home |
| Philips North America LLC | $43.17 | 2024 | (Bs2) Lm Undivided |
| Solventum Corporation | $33.63 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rogitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.